Case report: a case of R0 resection in a patient with PD-L1-negative, microsatellite-stabilized advanced pancreatic cancer after down-stage treatment with a PD-1 inhibitor in combination with chemotherapy
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a gastrointestinal tumor with high morbidity and mortality. Despite advances in diagnostic and therapeutic modalities, the outcome and prognosis of PDAC remain poor. Most patients have locally advanced disease (30%–35%) or distant metast...
Saved in:
| Main Authors: | Junqiang Dang, Qingqiang Wang, Yanling Yang, Lin Shang, Zeping Kang, Yu Jiang, Yanshun Ren, Hongjun Xiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-03-01
|
| Series: | Journal of Cancer Research and Clinical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00432-025-06147-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection
by: Elyar Abaydulla, et al.
Published: (2025-12-01) -
A case of pathological complete response with liposomal irinotecan + 5-FU/LV for unresectable locally advanced pancreatic cancer
by: Koji Kikuchi, et al.
Published: (2022-10-01) -
The efficacy and immune-mediated safety of PD-1/PD-L1 combined with neoadjuvant chemotherapy in triple-negative breast cancer: a meta-analysis
by: Xiao Yan, et al.
Published: (2025-08-01) -
Successful anti-PD-1 therapy in metastatic endometrial cancer with microsatellite instability: a case report
by: T. T. Andabekov, et al.
Published: (2019-07-01) -
N-glycosylation of PD-L1 modulates the efficacy of immune checkpoint blockades targeting PD-L1 and PD-1
by: Bar Kaufman, et al.
Published: (2025-05-01)